Skip to main content

Wealth Club Interview: Matt Currie (Seneca EIS Portfolio Fund)

Wealth Club Interview: Matt Currie (Seneca EIS Portfolio Fund)

Wealth Club: We met with Matt Currie of Seneca Partners to talk about their EIS funds. Seneca has raised and deployed over £100 million of EIS and VCT money into over 50 SMEs since launch, exiting 22 to date. The EIS Portfolio Fund offers a spread of AIM and private businesses. So what kind of companies go into the fund? What’s their track record on returns? Ultimately, why should EIS investors consider Seneca as an investment manager? Watch the interview to learn more.

Contents of this interview:

0:00 Introduction
1:42 What does Seneca’s EIS fund aim to do for investors?
2:45 What type of companies does Seneca invest in?
4:53 How active an investor is Seneca?
6:29 Investing in SkinBioTherapeutics – a company focusing on the gut-skin axis
7:41 Investing in Polarean imaging, which specialises in lung scanning
8:13 Investing in Wejo – Seneca’s first “unicorn”
9:06 How does Seneca work with investees to add value?
10:16 Seneca’s exit track record – including Mission Labs
12:00 How risky is EIS investment? How many companies will fail?
13:57 Summary: why should EIS investors choose Seneca?

The opinions expressed in this video are the interviewee’s own and do not necessarily reflect the view of Wealth Club Limited. This interview, like our service, is not advice and the products featured are not suitable for everyone. EIS investments are higher risk and less liquid than mainstream investments. You could lose your capital. Tax rules can change and tax benefits depend on your circumstances. If you’re unsure an investment is right for you, please seek professional advice.

Contact Us

Online form

If you have any questions about anything you’ve seen on our website then please get in touch. We are here to help. Normal office hours are weekdays 9.00am to 5.00pm. The office is not open on weekends or bank holidays.
  • Hidden
  • Before submitting this form, please confirm that you have read and agree with our website Terms & Conditions

  • This field is for validation purposes and should be left unchanged.